[go: up one dir, main page]

UY28911A1 - Profármacos de esteroides con acción androgénica - Google Patents

Profármacos de esteroides con acción androgénica

Info

Publication number
UY28911A1
UY28911A1 UY28911A UY28911A UY28911A1 UY 28911 A1 UY28911 A1 UY 28911A1 UY 28911 A UY28911 A UY 28911A UY 28911 A UY28911 A UY 28911A UY 28911 A1 UY28911 A1 UY 28911A1
Authority
UY
Uruguay
Prior art keywords
steroid
propharms
androgenic action
androgenic
action
Prior art date
Application number
UY28911A
Other languages
English (en)
Inventor
Alexander Hillisch
Sven Ring
Ralf Wyrwa
Peter Droescher
Walter Elger
Gudrun Reddersen
Birgitt Schneider
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of UY28911A1 publication Critical patent/UY28911A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0044—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Profármacos de esteroides con acción androgénica de la fórmula general (I), en los cuales el grupo Z está unido con el esteroide, composiciones farmacéuticas, que contienen estos compuestos, así como su uso para la preparación de medicamentos con acción androgénica.
UY28911A 2004-05-21 2005-05-20 Profármacos de esteroides con acción androgénica UY28911A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004025986A DE102004025986A1 (de) 2004-05-21 2004-05-21 Steroid-Prodrugs mit androgener Wirkung

Publications (1)

Publication Number Publication Date
UY28911A1 true UY28911A1 (es) 2005-12-30

Family

ID=34968657

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28911A UY28911A1 (es) 2004-05-21 2005-05-20 Profármacos de esteroides con acción androgénica

Country Status (22)

Country Link
EP (1) EP1747229A1 (es)
JP (1) JP2007538026A (es)
CN (1) CN1993375A (es)
AR (1) AR049547A1 (es)
AU (1) AU2005245568A1 (es)
BR (1) BRPI0510136A (es)
CA (1) CA2564963A1 (es)
CR (1) CR8785A (es)
DE (1) DE102004025986A1 (es)
EA (1) EA200602049A1 (es)
EC (1) ECSP067028A (es)
GT (1) GT200500122A (es)
IL (1) IL179293A0 (es)
MX (1) MXPA06013469A (es)
NO (1) NO20065885L (es)
PA (1) PA8633601A1 (es)
PE (1) PE20060271A1 (es)
SV (1) SV2006002123A (es)
TW (1) TW200613317A (es)
UY (1) UY28911A1 (es)
WO (1) WO2005113575A1 (es)
ZA (1) ZA200610769B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (de) 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
DE102005057224A1 (de) * 2005-11-29 2007-05-31 Bayer Schering Pharma Ag Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE102005057408A1 (de) * 2005-11-30 2007-05-31 Bayer Schering Pharma Ag Sulfamoylsulfonat-Prodrugs
CN101708338B (zh) * 2008-12-26 2014-06-04 中国人民解放军军事医学科学院放射与辐射医学研究所 含甾体结构的前药及其高度分散制剂
CN102964417A (zh) * 2012-11-30 2013-03-13 华中药业股份有限公司 17-羟基四氢吡喃醚甾族化合物的合成方法
CN107556258B (zh) * 2017-08-22 2021-06-04 湖北江田精密化学有限公司 一种4-氨基-2-氯-5(1h-四唑基-5)苯磺酰胺的制备方法
EP3533619A1 (en) * 2018-03-02 2019-09-04 Basf Se Heat sensitive recording material and color developer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH545316A (de) * 1970-07-17 1973-12-15 Hoffmann La Roche Verfahren zur Herstellung von Acylderivaten
US5001234A (en) * 1987-04-16 1991-03-19 The Upjohn Company Cyclic hydrocarbons with an aminoalkyl sidechain
US5571933A (en) * 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
DE19712488A1 (de) * 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben
DE10027887A1 (de) * 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen

Also Published As

Publication number Publication date
MXPA06013469A (es) 2007-01-23
AR049547A1 (es) 2006-08-16
WO2005113575A1 (de) 2005-12-01
TW200613317A (en) 2006-05-01
CA2564963A1 (en) 2005-12-01
ZA200610769B (en) 2008-08-27
PA8633601A1 (es) 2006-07-03
EA200602049A1 (ru) 2007-06-29
JP2007538026A (ja) 2007-12-27
NO20065885L (no) 2006-12-19
PE20060271A1 (es) 2006-05-25
DE102004025986A1 (de) 2005-12-15
EP1747229A1 (de) 2007-01-31
BRPI0510136A (pt) 2007-10-02
CR8785A (es) 2007-02-05
IL179293A0 (en) 2007-03-08
CN1993375A (zh) 2007-07-04
GT200500122A (es) 2006-01-24
AU2005245568A1 (en) 2005-12-01
ECSP067028A (es) 2006-12-29
SV2006002123A (es) 2006-02-15

Similar Documents

Publication Publication Date Title
UY32648A (es) Nuevos derivados de pirimidina y su uso en el tratamiento de enfermedades
CU20110204A7 (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750
ECSP11011390A (es) Compuestos espiro-amidas sustituidas
UY31524A1 (es) Nuevos compuestos 010
UY30748A1 (es) Compuesto0s novedosos
CR10489A (es) Derivados fenil-pirazol como ligandos de receptores glucocorticoides no esteroides
UY31048A1 (es) Nuevos compuestos de pirimidina y usos de los mismos
UY29002A1 (es) Nuevos derivados de hidantoína, procesos parasu preparación, composiciones farmacéuticas que los contienen y su uso en terapia
ECSP099620A (es) Derivados de ciclohexano espirociclico
UY31905A (es) Derivados de benzoxazinona, procesos de preparación, composiciones farmacéuticas conteniéndolos y aplicaciones.
UY31922A (es) Compuestos
UY32744A (es) Derivados de 2-carboxamida-7-piperazinil-benzofurano 774
CU20110185A7 (es) Nuevos derivados de compuestos de [3,2-c]pirazol esteroidal con actividad glucocorticoide
ECSP10010200A (es) Derivados de pirazol como inhibidores de 5-lo
UY29003A1 (es) Nuevos derivados de hidantoína, procesos para su preparación, composiciones farmacéuticas que los contienen y su uso en terapia
UY28911A1 (es) Profármacos de esteroides con acción androgénica
CR9595A (es) Derivados de benzofurarona como moduladores no esteroides de receptores de progesterona
UY31338A1 (es) Compuestos novedosos activos como antagonistas de receptores muscarinicos
UY28909A1 (es) Prodrogas de estradiol
UY28910A1 (es) Prodrogas de estriol y estetrol
ECSP11011501A (es) 17 -alquil-17 -oxi-estratrienos
ECSP13012372A (es) Nuevos derivados 1,4-diazepanos, inhibidores de pde-5.
UY32154A (es) Derivados de isoquinolinona, procesos para su preparacion, composiciones farmaceuticas que los contiene y su uso en terapia
PA8629401A1 (es) D-homo-17-cloro-16 (17) eno esteroides
UY28846A1 (es) D-homo-17-cloro-16 (17) eno esteroides

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160518